7NP-12464-27364 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-02-01
Dose 1 — Moderna
2021-02-26
Dose 2 — Moderna
2021-02-27
Registered in v-safe
2021-02-27
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain, Swelling · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-02-27
Survey response — day 21, dose 1
MedDRA: Pain in extremity — Feeling: Good

Free text: Sore arm

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-27
Report sent to call center — days 1–6 daily, dose 2
Be unable to work · Be unable to do your normal daily activities

1 call case(s)
2021-02-28
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Fatigue or tiredness, Nausea, Vomiting · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-02-28
Report sent to call center — days 1–6 daily, dose 2
Be unable to work · Be unable to do your normal daily activities

1 call case(s)
2021-08-27
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2022-01-07
Dose 3 — Moderna
2022-02-28
Health check-in — 12 months, dose 2
Feeling: Good

Adult check-in
2022-07-08
Survey response — 6 months, dose 3
MedDRA: Upper respiratory tract infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Upper respiratory infections

MedDRA releases: 2024-11 · check-in free text available
2023-01-09
Survey response — 12 months, dose 3
MedDRA: Nasopharyngitis, Productive cough, Respiratory tract congestion, Rhinorrhoea — Feeling: Good

MedDRA releases: 2024-11

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-02-01	Moderna
2	2021-02-26	Moderna
3	2022-01-07	Moderna	No

Call center

Reported	Outcome	VAERS-related outcome
2021-02-27	priority 2/3
2021-02-28	priority 2/3

Free text

Release 4 — day 21, dose 1

2021-02-27

Symptoms: Sore arm

Release 12 — 6 months, dose 3

2022-07-08

Symptoms: Upper respiratory infections

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Nasopharyngitis	·	·	✓
SD	Pain in extremity	✓	✓	✓
SD	Productive cough	·	·	✓
SD	Respiratory tract congestion	·	·	✓
SD	Rhinorrhoea	·	·	✓
SD	Upper respiratory tract infection	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release